A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus

NCT05887999 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: LY3532226
DRUG: Placebo

Sponsor

Eli Lilly and Company